1,591 results on '"Katzenellenbogen, John A."'
Search Results
102. A Set of Time-Resolved Fluorescence Resonance Energy Transfer Assays for the Discovery of Inhibitors of Estrogen Receptor-Coactivator Binding
103. Phenethyl pyridines with non-polar internal substitutents as selective ligands for estrogen receptor beta
104. Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta
105. A dual-acceptor time-resolved Föster resonance energy transfer assay for simultaneous determination of thyroid hormone regulation of corepressor and coactivator binding to the thyroid hormone receptor: Mimicking the cellular context of thyroid hormone action
106. Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-γ ligands: potential positron emission tomography imaging agents
107. Steroidal bivalent ligands for the estrogen receptor: Design, synthesis, characterization and binding affinities
108. Synthesis and evaluation of aryl-substituted diarylpropionitriles, selective ligands for estrogen receptor β, as positron-emission tomographic imaging agents
109. Phenol Red in Tissue Culture Media is a Weak Estrogen: Implications concerning the Study of Estrogen-Responsive Cells in Culture
110. Three-Dimensional Model for the Hormone Binding Domains of Steroid Receptors
111. Protease-Activated ``Prodrugs'' for Cancer Chemotherapy
112. Insect Pheromone Synthesis: New Methodology
113. Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
114. Experimental versus predicted affinities for ligand binding to estrogen receptor: iterative selection and rescoring of docked poses systematically improves the correlation
115. The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation
116. Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
117. Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
118. Radiosynthesis of [18F]talazoparib and biodistribution study in PC3 prostate tumor mice
119. Evaluation of a bromine-76-labeled progestin 16α,17α-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies
120. Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor
121. Extranuclear estrogen receptor-[alpha] stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis
122. Non-nuclear estrogen receptor α signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice
123. PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
124. CHRM1 is a Druggable Melanoma Target Whose Endogenous Activity is Determined by Inherited Genetic Variation in DOPA Production
125. Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis
126. William C. Eckelman: An anchor of stability with a quiet voice that nurtured a new field
127. Facile nucleophilic fluorination reactions using tert-alcohols as a reaction medium: significantly enhanced reactivity of alkali metal fluorides and improved selectivity
128. Convenient one-pot synthesis of 2,2-bis-(4-hydroxyphenyl)-cyclopentanone
129. Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor
130. Positron tomographic assessment of androgen receptors in prostatic carcinoma
131. Metabolite ligands of estrogen receptor-[beta] reduce primate coronary hyperreactivity
132. Estrogen Receptor-α Agonists Promote Angiogenesis in Human Myometrial Microvascular Endothelial Cells
133. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer
134. Non-Nuclear–Initiated Actions of the Estrogen Receptor Protect Cortical Bone Mass
135. Exploration of alcohol‐enhanced Cu‐mediated radiofluorination toward practical labeling.
136. Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[ 76Br]bromo-hydroxyflutamide
137. Chiral dimethylamine flutamide derivatives—modeling, synthesis, androgen receptor affinities and carbon-11 labeling
138. Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[ 18F]fluoro-4-nitronaphthyl)- cis-5-norbornene-endo-2,3-dicarboxylic imide
139. Chapter 21 Inhibitors of Nuclear Hormone Receptor/Coactivator Interactions
140. An efficient route for the preparation of a 21-fluoro progestin-16(alpha),17(alpha)-dioxolane, a high-affinity ligand for PET imaging of the progesterone receptor
141. Positron emission tomographic assessment of ”metabolic flare” to predict response of metastatic breast cancer to antiestrogen therapy
142. In Vitro and in Vivo Molecular Imaging of Estrogen Receptor α and β Homo- and Heterodimerization: Exploration of New Modes of Receptor Regulation
143. A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment
144. Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
145. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
146. Dual mechanism estrogen receptor inhibitors
147. OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
148. The tissue-specific effects of different 17β-estradiol doses reveal the key sensitizing role of AF1 domain in ERα activity
149. Long-Term Follow-Up and Treatment of a Female With Complete Estrogen Insensitivity
150. Abstract P5-05-05: Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.